Skip to content

Clinical trials

Phase 3 Dyslipidemias trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Phase 3 Country / region: Hungary Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20067
20071
20081
20121
20132
20141
20161
20171
20211
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda8
Amgen3
Novartis Pharmaceuticals3
89bio, Inc.1
AstraZeneca1
Hoffmann-La Roche1
Kowa Research Institute, Inc.1
Sanofi1
Solvay Pharmaceuticals1
Tanabe Pharma Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias21
Glucose Metabolism Disorders8
Diabetes Mellitus7
Diabetes Mellitus, Type 27
Hypercholesterolemia7
Hyperlipidemias5
Cardiovascular Diseases3
Hypertriglyceridemia2
Aortic Valve Stenosis1
Atherosclerosis1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.